A preferential p110{alpha}/{gamma} PI3K inhibitor attenuates experimental inflammation by suppressing the production of proinflammatory mediators in a NF-{kappa}B-dependent manner

N. M Dagia, G Agarwal, D. V Kamath, A Chetrapal Kunwar, R. D Gupte, M. G Jadhav, S. S Dadarkar, J Trivedi, A. A Kulkarni Almeida, F Kharas, L. C Fonseca, S Kumar and M. R. Bhonde

The American Journal of Physiology - Cell Physiology 298 ( 4 ): 929 - 941 , 2010